(Q47741981)

5 February 2018

title

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6. (English)

1 reference

5 February 2018

0 references

0 references

0 references

10

1 reference

5 February 2018

author name string

A Lin

1

1 reference

5 February 2018

G Kenis

2

1 reference

5 February 2018

S Bignotti

3

1 reference

5 February 2018

G J Tura

4

1 reference

5 February 2018

R De Jong

5

1 reference

5 February 2018

E Bosmans

6

1 reference

5 February 2018

R Pioli

7

1 reference

5 February 2018

C Altamura

8

1 reference

5 February 2018

S Scharpé

9

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

5 February 2018

published in

Schizophrenia Research

1 reference

5 February 2018

volume

32

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

9-15

1 reference

5 February 2018

Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Biological significance of soluble IL-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Is schizophrenia a viral or immunologic disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Seasonal variation in peripheral blood leukocyte subsets and in serum interleukin-6, and soluble interleukin-2 and -6 receptor concentrations in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

In vivo immunomodulatory effects of clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Elevated circulating levels of IL-6 in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Effects of clozapine on plasma cytokine and soluble cytokine receptor levels

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Preparation of monoclonal antibodies against the IL-6 signal transducer, gp130, that can inhibit IL-6-mediated functions

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Serum interleukin-6 in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

An immunologic study of the secretory products of rat Clara cells

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

A comprehensive macrophage-T-lymphocyte theory of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2898%2900034-6

7 January 2021

10.1016/S0920-9964(98)00034-6

Identifiers

DOI

1 reference

5 February 2018

1 reference

5 February 2018